Biotechnology is one of the strangest, scariest, sexiest, and most interesting corners of the stock market. In how many other industries are companies striving literally to save lives? Any industry ...

We'll know more about the company's medium-term prospects by the end of the year.

If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund ...

Biotech stocks have a way of making smart people do dumb things. It starts innocently enough. You read about a "breakthrough" that sounds like it came straight out of science fiction. A tiny company ...

Semaglutide — better known by its brand names Ozempic (for diabetes) and Wegovy (for weight loss) — received FDA approval in 2017. Since then, U.S. prescriptions have surged from roughly 6.1 billion ...

The biotech world is a prime target for risk-tolerant investors seeking out companies with the potential for dramatic gains. Firms in this space often either make it big—spiking upon news of a ...

Trevi Therapeutics shifts to late-stage biotech with Haduvio for IPF chronic cough. Click here to read my latest analysis of ...

Mon, August 4, 2025 at 11:15 AM UTC Viking Therapeutics (NASDAQ: VKTX) represents exactly this type of overlooked opportunity, trading at a valuation of just $3.7 billion as of Aug. 1, despite owning ...

However, there is one key reason the stock could still deliver outstanding returns over the long run: Its pipeline could help ...